Valneva SE (VALN)
8.69
-0.19
(-2.14%)
USD |
NASDAQ |
May 20, 11:44
Valneva 1 Year Total Returns (Daily): -27.03% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | -27.03% |
| May 16, 2024 | -33.22% |
| May 15, 2024 | -33.76% |
| May 14, 2024 | -36.60% |
| May 13, 2024 | -39.77% |
| May 10, 2024 | -38.68% |
| May 09, 2024 | -41.88% |
| May 08, 2024 | -40.85% |
| May 07, 2024 | -41.73% |
| May 06, 2024 | -41.73% |
| May 03, 2024 | -18.84% |
| May 02, 2024 | -23.52% |
| May 01, 2024 | -21.61% |
| April 30, 2024 | -21.12% |
| April 29, 2024 | -18.58% |
| April 26, 2024 | -19.41% |
| April 25, 2024 | -27.09% |
| April 24, 2024 | -25.98% |
| April 23, 2024 | -28.31% |
| April 22, 2024 | -26.67% |
| April 19, 2024 | -28.57% |
| April 18, 2024 | -28.05% |
| April 17, 2024 | -31.42% |
| April 16, 2024 | -29.48% |
| April 15, 2024 | -25.07% |
| Date | Value |
|---|---|
| April 12, 2024 | -26.76% |
| April 11, 2024 | -20.77% |
| April 10, 2024 | -19.56% |
| April 09, 2024 | -27.55% |
| April 08, 2024 | -22.43% |
| April 05, 2024 | -24.82% |
| April 04, 2024 | -22.60% |
| April 03, 2024 | -20.06% |
| April 02, 2024 | -24.68% |
| April 01, 2024 | -25.07% |
| March 28, 2024 | -20.80% |
| March 27, 2024 | -27.81% |
| March 26, 2024 | -21.62% |
| March 25, 2024 | -21.77% |
| March 22, 2024 | -31.00% |
| March 21, 2024 | -33.36% |
| March 20, 2024 | -32.51% |
| March 19, 2024 | -25.63% |
| March 18, 2024 | -27.48% |
| March 15, 2024 | -31.17% |
| March 14, 2024 | -35.43% |
| March 13, 2024 | -37.65% |
| March 12, 2024 | -35.31% |
| March 11, 2024 | -35.26% |
| March 08, 2024 | -38.58% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.05%
Minimum
Nov 29 2022
23.81%
Maximum
Jun 20 2023
-39.01%
Average
-36.60%
Median
May 14 2024
1 Year Total Returns (Daily) Benchmarks
| DBV Technologies SA | -70.08% |
| Cellectis SA | 66.11% |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | -11.59% |
| Innate Pharma SA | -10.27% |